Please ensure Javascript is enabled for purposes of website accessibility
Taylor Carmichael

Taylor Carmichael


Taylor Carmichael is a former attorney and filmmaker. He's the author of a line of murder mysteries, including Whodidit in the Supreme Court? and Whodidit With a Senator? The majority of what he knows about stocks he learned right here at the Motley Fool.

Recent articles


How Do You Stay Confident in a Market Crash?

Time is a great teacher.

Doctor Blight

This Game Could Make Your Kids Rich One Day

All my crypto holdings are underwater, except for one -- the coolest game on the blockchain.


3 Biotech Stocks With a Cash Pile Higher Than Their Valuations

Our roundtable found three biotechs with a nice cash cushion.


This Stock Is No. 1 on My Buy List

Digging into Appian's recent earnings report, I saw some amazing reasons to buy shares in 2022.


My Favorite Biotech

Here's why three contributors love 10x Genomics, Axsome Therapeutics, and Doximity.


10 Amazing Stocks Under $10

This bear market has crushed the stocks of some incredible early-stage companies. Here are 10 stocks that the market used to love and are now trading in the single digits.


10 Amazing Stocks Under $10 (Part II)

Because of this stock market crash, some wonderful stocks are super cheap in 2022. Here's a mini-portfolio of innovative companies trading under $10 a share right now.


3 Small-Caps That Might Be Acquisition Candidates

Here's why our roundtable thinks OptimizeRx, Affimed and Blueprint Medicines are all buys right now.


3 Healthcare Companies With Revenue Spiking 100% or More

Here's why three contributors are bullish on Outset Medical, Aurinia Pharmaceuticals, and Shockwave Medical.


4 Stocks That Could Turn $10,000 Into $200,000 by 2040

If you have a long investing time horizon, these strong performers could deliver massive gains.


The Risk/Reward for Opendoor Stock Is Amazing

While Opendoor might fail spectacularly in the iBuyer marketplace, the upside is so massive that a small investment in this small-cap makes sense.


The FDA Will Soon Give These 3 Healthcare Companies the Green Light

These contributors see happy news in the future for Novavax, Axsome Therapeutics, and Novocure.


This Tiny Medical Device Will Make Billions of Dollars

Inspire Medical Systems is radically transforming how we treat sleep apnea.


The Safest Healthcare Stocks in the World

Stryker, Johnson & Johnson, and Intuitive Surgical can be counted on to be steady performers in your portfolio.


3 Risky Stocks With Huge Potential Upside

Why risk-tolerant investors want to own Shopify, Silvergate Capital, and Pieris Pharmaceuticals.


These COVID Stocks Will Be Incredibly Profitable

As COVID-19 becomes endemic, what will the market look like for therapies and vaccines?


3 Pharmaceutical Stocks With Awesome Futures

The market is so pessimistic about anything COVID-related that everything has gotten super cheap.


It's Time to Be Bullish on COVID Stocks Again

Investors need to start thinking outside of the box.


This Cheap Stock Is Making Billions in Biotech

With FDA authorization likely on the horizon, Novavax is positioned for even greater success.


These Ridiculously Cheap Stocks Are Obvious Winners

The market has put these stocks on sale.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.